Skip to content

Cirrhosis Registry of Hospitalized Patients

Registry of Adult Consenting Patients Admitted to the Liver Unit With Liver Cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04767945
Acronym
RH7
Enrollment
2000
Registered
2021-02-23
Start date
2014-07-01
Completion date
2029-12-31
Last updated
2022-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascites, Cirrhosis, Liver, Encephalopathy, Frailty, Infection

Keywords

Cirrhosis, decompensation, frailty

Brief summary

Cirrhosis registry of consecutive adult consenting patients hospitalized with liver cirrhosis in the tertiary liver unit

Detailed description

On admission to F.D.Roosevelt Teaching Hospital / HEGITO Liver Unit (Div Hepatology, Gastroenterology and Liver Transplant), all the adult patients with liver cirrhosis are offered to participate. After providing informed consent, their demographic, clinical and laboratory / imaging data are uploaded by dedicated study person After discharge from the hospital, follow-up is recommended and uploaded to RH7 (if the follow-up visits take place at this institution \[FDR\]) Mortality data are uploaded from the national registry of dead on regular basis

Interventions

None listed

Sponsors

F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* liver cirrhosis (primarily on clinical grounds) * decompensating event leading to hospital admission * informed consent

Exclusion criteria

* declined consent

Design outcomes

Primary

MeasureTime frameDescription
Frequency and type of decompensation of liver cirrhosis1 yearRegistrations reflect cirrhosis prevalence; decompensation are acute, chronic, or acute-on-chronic
Mortality1 yearRecord mortality in registered cirrhotics

Secondary

MeasureTime frameDescription
Mortality90-dayRecord mortality in registered cirrhotics
FrailtyOn admissionMeasurement of the liver frailty index

Countries

Slovakia

Contacts

Primary ContactLubomir Skladany, MD, PhD
lubomir.skladany@gmail.com+421905482997
Backup ContactJanka Vnencakova, PhD
janka.vnencakova1@gmail.com+421902160743

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026